Table 3. Significantly altered metabolites in non-diabetic participants following RDIF.
|
m/z Ratio |
Fold Change |
Direction of change |
P-value |
KEGG ID |
Name of Metabolites |
Formula |
|
782.1 |
2.8605 |
Elevated |
0.013158 |
C00083 |
Malonyl coenzyme A |
C24H38N7O19P3S |
|
217.1 |
4.0485 |
Elevated |
0.017885 |
C00120 |
Biotin (Coenzyme R) |
C10H16N2O3S |
|
568.1 |
2.7272 |
Elevated |
0.02218 |
C11583 |
4-Glutathionyl cyclophosphamide |
C17H30Cl2N5O8PS |
|
441 |
2.2516 |
Elevated |
0.03017 |
C00081 |
Inosine 5'-triphosphate |
C10H15N4O14P3 |
|
397.2 |
0.10644 |
Reduced |
0.003117 |
C04717 |
13S-Hydroperoxy-9Z,11E-octadecadienoic acid |
C18H32O4 |
|
372.2 |
0.207 |
Reduced |
0.006399 |
C00445 |
5,10-Methenyltetrahydrofolate |
C20H22N7O6 |
|
701.1 |
0.3738 |
Reduced |
0.049228 |
C00006 |
Nicotinamide adenine dinucleotide phosphate (NADP+) |
C21H29N7O17P3 |
|
415.1 |
0.51669 |
Reduced |
0.004846 |
C00255 |
Riboflavin |
C17H20N4O6 |
|
371.2 |
0.51976 |
Reduced |
0.004714 |
C05011 |
4-Hydroxytamoxifen |
C26H29NO2 |
|
C16545 |
Tamoxifen N-oxide |
C26H29NO2 |
||||
|
C16544 |
alpha-Hydroxytamoxifen |
C26H29NO2 |
||||
|
C00473 |
Retinol (Vitamin A) |
C20H30O |
||||
|
C16682 |
9-cis-Retinol |
C20H30O |
||||
|
C00899 |
11-cis-Retinol |
C20H30O |
||||
|
272.2 |
0.52537 |
Reduced |
0.004521 |
C01137 |
S-Adenosylmethioninamine |
C14H23N6O3S |
Ramadan Diurnal Intermittent Fasting (RDIF)